Truist Financial Cuts HCA Healthcare (NYSE:HCA) Price Target to $495.00

HCA Healthcare (NYSE:HCA) had its target price reduced by equities researchers at Truist Financial from $535.00 to $495.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 27.98% from the company’s current price.

Other analysts have also issued research reports about the stock. Stephens decreased their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. KeyCorp lowered their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday. TD Cowen reduced their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Finally, JPMorgan Chase & Co. dropped their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $480.86.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $4.60 during mid-day trading on Monday, hitting $386.79. 133,803 shares of the company were exchanged, compared to its average volume of 1,331,207. The company has a market capitalization of $85.81 billion, a P/E ratio of 12.95, a PEG ratio of 1.29 and a beta of 1.12. HCA Healthcare has a 12-month low of $331.61 and a 12-month high of $556.52. The business’s 50 day simple moving average is $386.95 and its two-hundred day simple moving average is $453.56.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.84 EPS. Equities research analysts predict that HCA Healthcare will post 29.19 earnings per share for the current year.

Institutional Trading of HCA Healthcare

Institutional investors have recently added to or reduced their stakes in the business. Nomura Asset Management Co. Ltd. grew its position in HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Advisors Capital Management LLC grew its holdings in HCA Healthcare by 61.5% during the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Liberty Wealth Management LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter valued at about $1,905,000. Finally, Intech Investment Management LLC lifted its stake in shares of HCA Healthcare by 10.0% in the fourth quarter. Intech Investment Management LLC now owns 55,273 shares of the company’s stock worth $25,805,000 after acquiring an additional 5,019 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Quarterly results exceeded expectations: HCA reported second-quarter revenue of approximately $20.23 billion, up 8.7% year over year and above estimates, while adjusted earnings of $7.59 per share narrowly topped consensus. Net income reached about $1.7 billion. HCA Healthcare Q2 CY2026 sales top estimates
• Positive Sentiment: Florida Medicaid supported profitability: A Florida Medicaid program helped boost second-quarter profit, providing a favorable contribution to results. HCA Healthcare 2Q Profit Boosted by Florida Medicaid Program
• Positive Sentiment: Analysts remain broadly constructive: Oppenheimer lowered its price target to $485 but maintained an “outperform” rating, while KeyCorp reduced its target to $435 and kept an “overweight” rating. Both targets imply additional upside from the recent trading level. Analyst price-target updates
• Neutral Sentiment: Dividend announced: HCA declared a quarterly dividend of $0.78 per share, payable September 30 to shareholders of record September 16. The annualized yield is approximately 0.8%.
• Negative Sentiment: Full-year outlook was reduced: Management cut its 2026 profit outlook, tempering the impact of the quarterly beat and signaling pressure on expected earnings growth. HCA posts $1.7B net income and cuts 2026 profit outlook
• Negative Sentiment: Compliance concerns persist: A monitor identified potential noncompliance at Mission Health for the third consecutive year, creating regulatory and reputational risk. Mission monitor reports potential noncompliance
• Negative Sentiment: Coverage headwinds remain: ACA-related volume declines have reportedly shifted nearly one-for-one to uninsured patients, potentially pressuring payer mix and margins. HCA Healthcare ACA coverage disruptions
• Negative Sentiment: Price targets were broadly lowered: Robert W. Baird cut its target to $393 with a “neutral” rating, and Barclays reduced its target to $387 with an “equal weight” rating, reflecting more limited near-term upside. Analyst price-target reductions

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.